218 related articles for article (PubMed ID: 11158156)
1. Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera.
Watarai S; Yokota K; Tana ; Kishimoto T; Kanadani T; Taketa K; Oguma K
J Clin Microbiol; 2001 Feb; 39(2):798-800. PubMed ID: 11158156
[TBL] [Abstract][Full Text] [Related]
2. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives.
Stenger KO; Windler F; Karch H; von Wulffen H; Heesemann J
Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732
[TBL] [Abstract][Full Text] [Related]
4. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
5. Elevated tissue factor circulating levels in children with hemolytic uremic syndrome caused by verotoxin-producing E. coli.
Kamitsuji H; Nonami K; Murakami T; Ishikawa N; Nakayama A; Umeki Y
Clin Nephrol; 2000 May; 53(5):319-24. PubMed ID: 11305804
[TBL] [Abstract][Full Text] [Related]
6. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome.
Arbus GS
Kidney Int Suppl; 1997 Mar; 58():S91-6. PubMed ID: 9067954
[TBL] [Abstract][Full Text] [Related]
7. [The etiology and clinical features of hemolytic uremic syndrome].
Miyazaki S
Rinsho Ketsueki; 1994 Apr; 35(4):341-5. PubMed ID: 8028178
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte P1 group antigen expression in VTEC-associated hemolytic uremic syndrome.
Ashida A; Matsui K; Chizaki T; Yoshikawa K; Kawamura N; Suzuki K; Tamai H
Clin Nephrol; 1999 Feb; 51(2):73-6. PubMed ID: 10069641
[TBL] [Abstract][Full Text] [Related]
9. Does blood type B protect against haemolytic uraemic syndrome? An analysis of the 1996 Sakai outbreak of Escherichia coli O157:H7 (VTEC O157) infection. The Osaka HUS Critical Care Study Group.
Shimazu T; Shimaoka M; Sugimoto H; Taenaka N; Hasegawa T
J Infect; 2000 Jul; 41(1):45-9. PubMed ID: 10942639
[TBL] [Abstract][Full Text] [Related]
10. [Hemolytic uremic syndrome].
Arai T; Matsuzaki K
Nihon Rinsho; 1996 Sep; 54(9):2551-60. PubMed ID: 8890593
[TBL] [Abstract][Full Text] [Related]
11. Vero cytotoxin binding to polymorphonuclear leukocytes among households with children with hemolytic uremic syndrome.
te Loo DM; Heuvelink AE; de Boer E; Nauta J; van der Walle J; Schröder C; van Hinsbergh VW; Chart H; van de Kar NC; van den Heuvel LP
J Infect Dis; 2001 Aug; 184(4):446-50. PubMed ID: 11471102
[TBL] [Abstract][Full Text] [Related]
12. Changes in the postenteropathic form of the hemolytic uremic syndrome in children.
Coad NA; Marshall T; Rowe B; Taylor CM
Clin Nephrol; 1991 Jan; 35(1):10-6. PubMed ID: 1801761
[TBL] [Abstract][Full Text] [Related]
13. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
Gerber A; Karch H; Allerberger F; Verweyen HM; Zimmerhackl LB
J Infect Dis; 2002 Aug; 186(4):493-500. PubMed ID: 12195376
[TBL] [Abstract][Full Text] [Related]
14. Risk of haemolytic uraemic syndrome caused by shiga-toxin-producing Escherichia coli infection in adult women in Japan.
Fujii J; Mizoue T; Kita T; Kishimoto H; Joh K; Nakada Y; Ugajin S; Naya Y; Nakamura T; Tada Y; Okabe N; Maruyama Y; Saitoh K; Kurozawa Y
Epidemiol Infect; 2016 Apr; 144(5):952-61. PubMed ID: 26470913
[TBL] [Abstract][Full Text] [Related]
15. Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome.
Raffaelli RM; Paladini M; Hanson H; Kornstein L; Agasan A; Slavinski S; Weiss D; Fennelly GJ; Flynn JT
Pediatr Infect Dis J; 2007 Oct; 26(10):951-3. PubMed ID: 17901803
[TBL] [Abstract][Full Text] [Related]
16. [Verotoxin induced hemolytic uremic syndrome: pathophysiology of neurological involvement].
Takagi C; Naruse T
Nihon Rinsho; 1997 Mar; 55(3):731-5. PubMed ID: 9086789
[TBL] [Abstract][Full Text] [Related]
17. Role of non-polio enterovirus infection in pediatric hemolytic uremic syndrome.
De Petris L; Gianviti A; Caione D; Innocenzi D; Edefonti A; Montini G; De Palo T; Tozzi AE; Caprioli A; Rizzoni G
Pediatr Nephrol; 2002 Oct; 17(10):852-5. PubMed ID: 12376816
[TBL] [Abstract][Full Text] [Related]
18. Two cases of human urinary tract infection complicated by hemolytic uremic syndrome caused by verotoxin-producing Escherichia coli.
Scheutz F; Olesen B; Nørgaard A
Clin Infect Dis; 2000 Sep; 31(3):815-6. PubMed ID: 11017837
[TBL] [Abstract][Full Text] [Related]
19. Shiga toxin-producing Escherichia coli infection.
Thorpe CM
Clin Infect Dis; 2004 May; 38(9):1298-303. PubMed ID: 15127344
[TBL] [Abstract][Full Text] [Related]
20. Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005.
Karpac CA; Lee A; Kunnel BS; Bamgbola OF; Vesely SK; George JN
J Okla State Med Assoc; 2007 Nov; 100(11):429-33. PubMed ID: 18183860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
